Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

YM-872 shows potential for stroke in animal models

Aug. 13, 1997

Antiischemic activity of calmodulin antagonist reported

Aug. 13, 1997

NR2B-selective NMDA antagonist for occlusive stroke

Aug. 13, 1997

Bradykinin antagonist shows potential in stroke and ischemic disorders

Aug. 13, 1997

YM90K efficacy shown in rat model of cerebral ischemia

Aug. 13, 1997

Endothelin antagonists for cerebral ischemia

Aug. 13, 1997

P&U antioxidant shows cerebroprotective activity in rats

Aug. 13, 1997

Elan licenses Morphelan to Targon Corporation

Aug. 13, 1997

Imminent launch of Novartis' Alzheimer's disease therapy

Aug. 12, 1997

Metabolic studies on sameridine described at ISSX meeting

Aug. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...